Morpheus Ventures — 2022 Investments
3 investments dated 2022 · listed companies and verified rows first · show all
VeriSIM uses machine learning and computational simulation to accelerate drug development, replacing traditional trial-and-error experimentation with computational prediction to improve success rates and reduce animal testing.
AI & Machine LearningBiotechDigital HealthMedical Devices
Jo Varshney(Founder)in
Co-investorsAmplify PartnersCerity Partners VenturesIntel CapitalLoup VenturesOCA VenturesTwin Ventures+3 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Bosscat Home Services and TechnologiesPunchList USA
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.